Health Cor Management, L.P. Ironwood Pharmaceuticals Inc Transaction History

Health Cor Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$11.92 - $13.92 $6.23 Million - $7.28 Million	-522,712 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $2.17 Million - $2.8 Million	-213,489 Reduced 29.0%	522,712 $6.73 Million
Q1 2021 May 17, 2021	BUY	$9.04 - $11.86 $6.66 Million - $8.73 Million	736,201 New	736,201 $8.23 Million
Q3 2019 Nov 14, 2019	SELL	$8.59 - $10.96 $4.3 Million - $5.48 Million	-500,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$9.8 - $12.89 $2.42 Million - $3.19 Million	-247,198 Reduced 33.08%	500,000 $5.47 Million

Q1 2019 May 15, 2019	BUY	$8.27 - $12.73 $6.18 Million - $9.51 Million	747,198 New	747,198 $10.1 Million

296

170M

27.1M

2.28M

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $999M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.